Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

British Journal of Pharmacology

Volumn 132, Issue 8, 2001, Pages 1650-1656

  Ryan, R E ^a   Ross, S A ^b   Drago, J ^b   Loiacono, R E ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

6 hydroxydopamine; Knockout; Methamphetamine; Neurodegeneration; Nicotine; nicotinic receptor; Parkinson's disease; 4 nicotinic receptor subunit

Indexed keywords

ALPHA 4 NICOTINIC RECEPTOR; MAZINDOL; METHAMPHETAMINE; NICOTINE; NICOTINIC RECEPTOR; OXIDOPAMINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CHRONOPHARMACOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; INFUSION; INJECTION; KNOCKOUT MOUSE; MOUSE; NERVE DEGENERATION; NERVE ENDING; NEUROPROTECTION; NONHUMAN; OSMOTIC MINIPUMP; PARKINSONISM; PRIORITY JOURNAL; SURVIVAL;

EID: 0035036071     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703989     Document Type: Article

References (49)

1. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
2. Cigarette smoking and Parkinson's Disease
3. Regional variation in the effects of nicotine on catecholamine overflow in rat brain
4. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats
5. Chronic continuous infusion of (-)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat
6. Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement
7. Functional anatomy of nicotinic acetylcholine receptors in mammalian brain
8. 3H]-dopamine release
9. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
10. 6-hydroxydopamine lesion of rat nigrostriatal dopaminergic neurons differentially affects nicotinic acetylcholine receptor subunit mRNA expression
11. Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo
12. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilisation in substantia nigra and in surviving forebrain dopaminergic nerve terminal systems after partial di-mesencephalic hemitransection
13. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
14. 3H]dopamine release from mouse striatal synaptosomes
15. 3H]dopamine release from synaptosomes prepared from mouse striatum
16. Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction
17. Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists
18. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemistransection
19. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse
20. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tertrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse
21. Chronic nicotine treatment counteracts dopamine D2 receptor upregulation induced by a partial meso-diencephalic hemitransection in the rat
22. Chronic nicotine treatment counteracts the decrease in extracellular dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: A microdialysis study
23. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat
24. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites
25. 3H]mazindol autoradiography
26. Nicotine protects cultures cortical neurons against glutamate-induced cytotoxicity via α7-neuronal receptors and neuronal CNS receptors
27. Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity
28. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat
29. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states
30. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
31. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors
32. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism
33. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats
34. Cigarette smoking and protection from Parkinson's Disease: False association or etiologic clue?
35. Etiology and pathogenesis of Parkinson's Disease
36. Chronic nicotine treatment eliminates asymmetry in striatal glucose utilisation following unilateral transection of the mesostriatal dopamine pathway in rats
37. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine
38. Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically
39. Phenotypic characterisation of an α4 neuronal nicotinic acetylcholine receptor subunit knockout mouse
40. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors
41. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
42. Nicotine protects against dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons
43. UB-165: A novel nicotinic agonist with subtype selectivity implicates the α4/β2* subtype in the modulation of dopamine release from rat striatal synaptosomes
44. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity
45. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice
46. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats
47. The paradox of acetylcholine receptor upregulation by nicotine
48. Presynaptic nicotinic ACh receptors